A Pathogenic Smoke Associated Neutrophilic Exosomal Pathway.
致病性烟雾相关的中性粒细胞外泌体途径。
基本信息
- 批准号:10416774
- 负责人:
- 金额:$ 37.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AlveolarAntibodiesBindingBiological MarkersBiologyCellsCharacteristicsChronic Obstructive Pulmonary DiseaseCollagen Type IComplexCoughingDevelopmentDiseaseDisease ProgressionDisease modelDissociationEarly identificationExcisionExtracellular MatrixExtracellular Matrix ProteinsFutureGenerationsGoalsGrantHumanIn VitroIndividualInflammationInflammatoryIntegrinsLeukocyte ElastaseLinkLiquid substanceLungLysineMacrophage-1 AntigenMeasuresMembraneMethodsModelingMolecularMusPaperPathogenesisPathogenicityPathway interactionsPatientsPeptide HydrolasesPhasePhenotypePopulationProductionProtaminesProtease InhibitorProteoglycanPulmonary EmphysemaRIPK3 geneResistanceRespiratory FailureRisk FactorsRoleSamplingSerine ProteaseSerumSeverity of illnessShortness of BreathSiteSmokeSmokerSmokingSputumSurfaceTherapeuticWorkairway obstructionalpha 1-Antitrypsinalveolar destructionchronic inflammatory diseasecohortdisease phenotypeexosomeexposure to cigarette smokehigh riskimprovedin vivoinhibitormouse modelnanovesicleneutrophilnever smokernon-smokingpancreatic elastase IIpatient stratificationrisk stratificationsmoking-related lung diseasetherapeutic target
项目摘要
Project Summary
Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory disease believed to be driven
by protease-antiprotease imbalance. The mechanisms leading to this imbalance have yet to be fully
understood. Recent work has suggested that exosomes (small nanovesicles released by cells) from
activated neutrophils (PMNs) are coated in neutrophil elastase (NE) from degranulated PMNs and this
exosome associated NE renders it protected from its native antiprotease, alpha-1-antitrypsin (α1AT).
This resistance to α1AT makes exosome associated NE several log-fold more potent in causing a COPD
disease-like phenotype in mouse models than free NE in solution. These PMN exosomes can bind to
type I collagen and degrade structural extracellular matrix (ECM) proteins. Of bigger significance, these
PMN derived NE+ exosomes can cause alveolar destruction in a mouse model and these NE+ exosomes
can be found in the BALF of COPD patients, but not healthy never smoker controls, indicating an
important role for exosome associated NE in COPD disease progression. This grant will identify the
mechanism of NE association to the surface of PMN exosomes as well as focusing on molecules to
disrupt this association, rendering the NE susceptible to α1AT inactivation. Furthermore, this grant will
develop a smoking mouse model of NE+ PMN exosome production and disease transfer to naïve mice,
effectively creating a mouse-mouse transfer model of disease. Additionally, this grant will correlate the
presence of PMN NE+ exosomes in COPD patient BALF with other significant parameters of COPD
severity. Moreover, PMN derived NE+ exosomes from other, less invasive patient fluid samples, serum
and sputum, will be quantified and their ability to transfer disease to mouse model of COPD will be
compared to those from patient BALF. Additionally, substances studied that can dissociate NE from the
exosome surface can be developed into potential therapeutic targets.
项目摘要
慢性阻塞性肺疾病(COPD)是一种慢性炎症性疾病,被认为是驱动的
通过蛋白酶 - 抗蛋白酶不平衡。导致这种失衡的机制尚未完全
理解。最近的工作表明,外泌体(细胞释放的小纳米植物)
活化的嗜中性粒细胞(PMN)在脱粒PMN中覆盖在中性粒细胞弹性酶(NE)中,这
外泌体相关的NE提供了其免受天然抗蛋白酶Alpha-1-抗抗蛋白酶(α1AT)的保护。
这种对α1AT的抗性使外泌体的NE在引起COPD时具有更多的对数的潜力
小鼠模型中的疾病样表型比溶液中的游离NE。这些PMN外泌体可以结合
I型胶原蛋白和结构性细胞外基质(ECM)蛋白质。具有更大的意义,这些
PMN衍生的NE+外泌体可能在小鼠模型中引起肺泡破坏,这些NE+外泌体
可以在COPD患者的BALF中找到,但不健康,从不吸烟者对照,表明
与外泌体NE相关的重要作用在COPD疾病进展中。该赠款将确定
NE与PMN外泌体表面的结合机制,并专注于分子
破坏这种关联,使NE容易受到α1AT失活的影响。此外,这笔赠款将
开发NE+ PMN外泌体产生和疾病转移到幼稚小鼠的吸烟小鼠模型,
有效地创建疾病的小鼠转移模型。此外,该赠款将与
COPD患者BALF中存在PMN NE+外泌体,并具有COPD的其他重要参数
严重程度。此外,PMN从其他侵入性的患者流体样本,串行中得出的NE+外泌体
和痰液,将被量化,它们将疾病转移到小鼠COPD模型的能力将是
与患者BALF相比。另外,可以从事分离ne的物质
外泌体表面可以发展为潜在的治疗靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kristopher R. Genschmer其他文献
Kristopher R. Genschmer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kristopher R. Genschmer', 18)}}的其他基金
A Pathogenic Smoke Associated Neutrophilic Exosomal Pathway.
致病性烟雾相关的中性粒细胞外泌体途径。
- 批准号:
10614014 - 财政年份:2022
- 资助金额:
$ 37.13万 - 项目类别:
相似国自然基金
靶向CLDN18.2抗体的抗原结合特性对CAR-T抗肿瘤活性的调控机制
- 批准号:82303716
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SMAD结合蛋白HMCES在抗体多样性成熟中的功能机制探究
- 批准号:32370753
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
活化针对新冠病毒抗原受体结合域(RBD)高度保守表位的中和抗体策略研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活化针对新冠病毒抗原受体结合域(RBD)高度保守表位的中和抗体策略研究
- 批准号:82202026
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
马尔尼菲篮状菌Noc2蛋白靶向结合CD19诱导B细胞产生抗IFN-γ自身抗体的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
相似海外基金
Bio-Responsive and Immune Protein-Based Therapies for Inhibition of Proteolytic Enzymes in Dental Tissues
用于抑制牙齿组织中蛋白水解酶的基于生物响应和免疫蛋白的疗法
- 批准号:
10555093 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
Role of neonatal lung macrophages in mediating resilience to hyperoxia induced lung injury via TREM2 signaling
新生儿肺巨噬细胞通过 TREM2 信号传导介导高氧诱导肺损伤的恢复能力
- 批准号:
10720557 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
Pilot Project Investigating the PAX3-FOXO1 Protein in the Rare Disease Rhabdomyosarcoma
研究罕见疾病横纹肌肉瘤中 PAX3-FOXO1 蛋白的试点项目
- 批准号:
10727279 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
Interleukin-27 in host response to Legionella infection
Interleukin-27 在宿主对军团菌感染的反应中
- 批准号:
10745091 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别: